In a patient with a history of leukemia in remission under surveillance who develops infected eczema, what signs or findings should prompt evaluation for leukemia recurrence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Monitoring for Leukemia Recurrence in a Patient with Infected Eczema

In a patient with prior leukemia in remission who develops infected eczema, you must immediately obtain a complete blood count with differential and peripheral blood smear, and maintain a very low threshold to biopsy any persistent, atypical, or treatment-resistant skin lesions to rule out leukemia cutis, which can herald systemic relapse.

Key Warning Signs to Watch For

Hematologic Parameters

The most critical initial step is laboratory evaluation 1:

  • Complete blood count with manual differential - Look specifically for:
    • New or worsening cytopenias (anemia, thrombocytopenia, leukopenia)
    • Peripheral blood blasts
    • Abnormal leukocyte differential
  • Peripheral blood smear review - Essential for detecting circulating blasts that may not be apparent on automated counts 1
  • Reticulocyte count - Helps distinguish bone marrow failure from other causes of cytopenia 2

Cutaneous Red Flags Requiring Biopsy

Biopsy any skin lesion that exhibits these characteristics 3, 4, 5:

  • Fails to respond to appropriate antimicrobial therapy within expected timeframe
  • Infiltrated papules, nodules, or plaques - especially if erythematous or violaceous
  • Rapidly progressive or spreading lesions despite treatment
  • Unusual distribution or morphology inconsistent with typical eczema
  • Fungating, ulcerated, or hemorrhagic lesions
  • Lesions at sites of prior trauma or procedures (Koebner-like phenomenon) 6

The evidence is clear: leukemia cutis can present as the first and only sign of relapse, even when bone marrow remains in remission 3, 7, 8. Multiple case reports document isolated extramedullary cutaneous relapse occurring years after successful treatment.

Clinical Examination Priorities

Beyond the skin, perform focused assessment for 2:

  • Constitutional symptoms: Progressive fatigue, fever, night sweats, unintentional weight loss
  • Bleeding manifestations: New petechiae, bruising, epistaxis
  • Organomegaly: Splenomegaly, hepatomegaly, lymphadenopathy
  • Neurologic symptoms: Headaches, cranial nerve deficits (may indicate CNS involvement)

Surveillance Frequency

If the CBC and skin lesions are concerning, do not wait 2:

  • Repeat CBC within 2-4 weeks if abnormal or worsening
  • Proceed directly to bone marrow evaluation if peripheral blasts are detected or cytopenias worsen
  • For stable patients with normal counts, continue surveillance CBC at minimum annually, though every 3-6 months is reasonable given history 2

When to Escalate to Bone Marrow Evaluation

Obtain bone marrow aspirate and biopsy with full workup (morphology, flow cytometry, cytogenetics, molecular studies) if 1:

  • Peripheral blood shows blasts or unexplained cytopenias
  • Skin biopsy confirms leukemia cutis
  • Progressive or new cytopenias develop
  • Clinical suspicion remains high despite negative initial testing

Critical Pitfall to Avoid

The most dangerous error is dismissing persistent or atypical skin lesions as simple infection or dermatitis 5. The literature repeatedly emphasizes that leukemia cutis can mimic benign conditions, including:

  • Cellulitis or bacterial infection
  • Allergic drug reactions
  • Chronic dermatitis

One case report specifically describes a lesion initially thought to be antibiotic-related rash that proved to be leukemia cutis on biopsy 5. Another documents leukemia cutis presenting as "eczema with infection" that was actually isolated extramedullary relapse 8.

Special Considerations for Infected Eczema

The presence of infection complicates assessment because:

  • Infection itself can cause reactive changes in blood counts
  • Inflammatory skin changes may obscure underlying infiltration
  • Immunosuppression from prior leukemia treatment increases infection susceptibility 9

Therefore, if skin lesions persist beyond 7-10 days of appropriate antimicrobial therapy, biopsy is mandatory 4. The biopsy should include immunohistochemistry and flow cytometry if sufficient tissue is obtained 10.

Patient Education

Inform the patient to seek immediate evaluation for 2:

  • Progressive fatigue or weakness
  • New bleeding or bruising
  • Persistent fever
  • Any new skin lesions or changes in existing lesions
  • Worsening of treated skin lesions

The evidence demonstrates that leukemia cutis in the setting of relapsed disease carries particularly poor prognosis 4, making early detection through vigilant monitoring essential for any chance of successful salvage therapy.

References

Research

Recurrent leukemia cutis in acute myeloblastic leukemia.

Henry Ford Hospital medical journal, 1989

Research

A transient cutaneous relapse of AML M1 in hematological remission: a case report.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2017

Guideline

acute myeloid leukemia, version 3.2023, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.